SMITH ASSET MANAGEMENT GROUP LP - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q3 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.

Quarter-by-quarter ownership
SMITH ASSET MANAGEMENT GROUP LP ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q4 2018$2,379,000
-18.9%
23,780
-7.1%
0.08%
+1.2%
Q3 2018$2,933,000
+14.6%
25,600
-10.3%
0.08%
+12.2%
Q2 2018$2,559,000
+6.6%
28,540
-13.0%
0.07%
-6.3%
Q1 2018$2,400,000
-31.7%
32,810
-45.8%
0.08%
-28.2%
Q4 2017$3,514,000
+58466.7%
60,510
+32785.9%
0.11%
Q1 2014$6,000
-25.0%
1840.0%0.00%
Q4 2013$8,000
+14.3%
1840.0%0.00%
Q3 2013$7,000
-12.5%
1840.0%0.00%
Q2 2013$8,0001840.00%
Other shareholders
HAEMONETICS CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Iron Triangle Partners LP 330,000$36,633,0004.66%
BEACONLIGHT CAPITAL, LLC 156,395$17,361,0002.80%
Bridge City Capital, LLC 48,011$5,330,0001.77%
Summit Creek Advisors LLC 121,362$13,472,0001.61%
Sivik Global Healthcare LLC 25,000$2,775,0001.01%
ANCHOR CAPITAL ADVISORS LLC 412,218$45,760,0000.97%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 69,655$7,732,0000.90%
Orbimed Advisors 852,000$94,581,0000.88%
LONDON CO OF VIRGINIA 1,057,738$117,420,0000.67%
WEXFORD CAPITAL LP 40,138$4,456,0000.66%
View complete list of HAEMONETICS CORP shareholders